Miguel López‐Botet

Author

Miguel López‐Botet

Also Known As

L Jurado, M Lopez-Botet, M LÓPEZ-BOTET, M López Botet, M López-Botet, M. LOPEZ‐BOTET, M. Lopez-Botet, M. Lopez‐Botet, M. LÓPEZ‐BOTET, M. López-Botet

245

Publications

16.8K

Citations

H-Index

114

Concepts

All Affiliations

Universitat Pompeu Fabra Hospital Universitario de La Princesa Hospital Del Mar Hospital del Mar Research Institute Universidad Autónoma de Madrid

About

Miguel López‐Botet is an author at Universitat Pompeu Fabra specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	54	5.6K
2	Allergy	13	13	2.1K
3	Health Sciences	2	2	992
4	Natural Sciences	2	2	39
5	Public Health	1	1	27

Miguel López‐Botet

144

Publications

13.9K

Citations

H-Index

Page 1

	Year	Citations
HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A Ni Lee, Manuel Llano, Marta Carretero, Proceedings of the National Academy of Sciences Major LigandAutoimmune DiseaseAllergyHla ImmunogeneticsImmunology	1998	1K
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) Andrea Cossarizza, Hyun‐Dong Chang, Andreas Radbruch, European Journal of Immunology Laboratory ImmunologyImmunologyPathologyImmunophenotypingImmune System	2019	965
A Common Inhibitory Receptor for Major Histocompatibility Complex Class I Molecules on Human Lymphoid and Myelomonocytic Cells Marco Colonna, Francisco Navarro, Teresa Bellón, The Journal of Experimental Medicine	1997	924
Imprint of human cytomegalovirus infection on the NK cell receptor repertoire Mónica Gumá, Ana Angulo, Carlos Vilches, Blood	2004	826
Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts Mónica Gumá, Matthias Budt, Andrea Sáez, Blood	2005	433
HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer Manuel Llano, Ni Lee, Francisco Navarro, European Journal of Immunology	1998	373
The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells Francisco Navarro, Manuel Llano, Teresa Bellón, European Journal of Immunology	1999	356
Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. Marta Cebrián, E Yagüe, Mercedes Rincón, The Journal of Experimental Medicine Novel Activation AntigenLymphocyte DevelopmentImmunologyImmune RegulationImmunologic Mechanism	1988	281
The CD94 and NKG2‐A C‐type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules Marta Carretero, Claudia Cantoni, Teresa Bellón, European Journal of Immunology	1997	275
Selective expansion of intraepithelial lymphocytes expressing the HLA-E–specific natural killer receptor CD94 in celiac disease Bana Jabrì, Natacha Patey‐Mariaud de Serre, Christophe Cellier, Gastroenterology	2000	257

Page 1